Topical combinations to treat microvascular dysfunction of chronic postischemia pain

Anesthesia and Analgesia

Volumn 118, Issue 4, 2014, Pages 830-840

  Laferrière, André ^a   Abaji, Rachid ^a   Tsai, Cheng Yu Mark ^b   Ragavendran, J Vaigunda ^a   Coderre, Terence J ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b Department of Psychology ^*  (India)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE; LINSIDOMINE; LISOFYLLINE; PENTOXIFYLLINE; PHOSPHATIDIC ACID; TETRAZOLIUM;

ALLODYNIA; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; CAPILLARY FLOW; CHRONIC PAIN; CONTROLLED STUDY; DOSE RESPONSE; HYPEREMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, TOPICAL; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; CAPILLARIES; CHEMISTRY, PHARMACEUTICAL; CHRONIC PAIN; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; HYPERALGESIA; HYPEREMIA; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MOLSIDOMINE; NITRIC OXIDE DONORS; OINTMENTS; PAIN MEASUREMENT; PHOSPHATIDIC ACIDS; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, LONG-EVANS; REGIONAL BLOOD FLOW;

EID: 84896950411     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000141     Document Type: Article

References (59)

1. Kurvers HA, Jacobs MJ, Beuk RJ, Van den Wildenberg FA, Kitslaar PJ, Slaaf DW, Reneman RS. Reflex sympathetic dystrophy: evolution of microcirculatory disturbances in time. Pain 1995;60: 333-40
2. Matsumura H, Jimbo Y, Watanabe K. Haemodynamic changes in early phase reflex sympathetic dystrophy. Scand J Plast Reconstr Surg Hand Surg 1996;30: 133-8
3. Schürmann M, Zaspel J, Gradl G, Wipfel A, Christ F. Assessment of the peripheral microcirculation using computer-assisted venous congestion plethysmography in post-traumatic complex regional pain syndrome type I. J Vasc Res 2001;38: 453-61
4. Dayan L, Salman S, Norman D, Vatine JJ, Calif E, Jacob G. Exaggerated vasoconstriction in complex regional pain syndrome- 1 is associated with impaired resistance artery endothelial function and local vascular reflexes. J Rheumatol 2008;35: 1339-45
5. Koban M, Leis S, Schultze-Mosgau S, Birklein F. Tissue hypoxia in complex regional pain syndrome. Pain 2003;104: 149-57
6. Coderre TJ, Xanthos DN, Francis L, Bennett GJ. Chronic post- ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 2004;112: 94-105
7. Xanthos DN, Bennett GJ, Coderre TJ. Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain. Pain 2008;137: 640-51
8. Laferrière A, Millecamps M, Xanthos DN, Xiao WH, Siau C, de Mos M, Sachot C, Ragavendran JV, Huygen FJ, Bennett GJ, Coderre TJ. Cutaneous tactile allodynia associated with microvascular dysfunction in muscle. Mol Pain 2008;4: 49
9. Ragavendran JV, Laferriere A, Khorashadi M, Coderre TJ. Pentoxifylline reduces chronic post-ischemia pain by alleviating microvascular dysfunction. Eur J Pain 2014; in press. Jul 31. doi: 10.1002 j.1532-2149.2013.00381.x. [Epub ahead of print]
10. Giessler C, Wangemann T, Silber RE, Dhein S, Brodde OE. Noradrenaline-induced contraction of human saphenous vein and human internal mammary artery: involvement of different alpha-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 2002;366: 104-9
11. Hrometz SL, Edelmann SE, McCune DF, Olges JR, Hadley RW, Perez DM, Piascik MT. Expression of multiple alpha1- adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 1999;290: 452-63
12. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327: 524-6
13. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 1987;39: 163-96
14. Cubeddu LX. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Am Heart J 1988;116: 133-62
15. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 2002;90: 21-8
16. Weiss B, Hait WN. Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents. Annu Rev Pharmacol Toxicol 1977;17: 441-77
17. Rybalkin SD, Beavo JA. Multiplicity within cyclic nucleotide phosphodiesterases. Biochem Soc Trans 1996;24: 1005-9
18. Lincoln TM. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 1989;41: 479-502
19. Horlington M, Watson PA. Inhibition of 3'5'-cyclic-AMP phosphodiesterase by some platelet aggregation inhibitors. Biochem Pharmacol 1970;19: 955-6
20. Jacoby D, Mohler ER 3rd. Drug treatment of intermittent claudication. Drugs 2004;64: 1657-70
21. Robless P, Mikhailidis DP, Stansby GP: Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 2007; CD003748
22. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP. Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock 1999;11: 269-75
23. Rice GC, Brown PA, Nelson RJ, Bianco JA, Singer JW, Bursten S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci U S A 1994;91: 3857-61
24. Davis KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991;47: 309-17
25. Reuben SS, Sklar J. Intravenous regional anesthesia with clonidine in the management of complex regional pain syndrome of the knee. J Clin Anesth 2002;14: 87-91
26. Manahan AP, Burkman KA, Malesker MA, Benecke GW. Clinical observation on the use of topical nitroglycerin in the management of severe shoulder-hand syndrome. Nebr Med J 1993;78: 87-9
27. Groeneweg G, Niehof S, Wesseldijk F, Huygen FJ, Zijlstra FJ. Vasodilative effect of isosorbide dinitrate ointment in complex regional pain syndrome type 1. Clin J Pain 2008;24: 89-92
28. Cocco G, Strozzi C, Haeusler G, Chu D, Amrein R, Padovan GC. The therapeutic value of clonidine in patients with coronary heart disease. Eur J Cardiol 1979;10: 221-8
29. Insel J, Halle AA, Mirvis DM. Efficacy of pentoxifylline in patients with stable angina pectoris. Angiology 1988;39: 514-9
30. Messin R, Fenyvesi T, Carreer-Bruhwyler F, Crommen J, Chiap P, Hubert P, Dubois C, Famaey JP, Géczy J. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations. Eur J Clin Pharmacol 2003;59: 227-32
31. Sternitzky R, Seige K. Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. Curr Med Res Opin 1985;9: 602-10
32. Maksimović ZV. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities]. Srp Arh Celok Lek 1999;127: 249-53
33. Kukushkin ML, Smirnova VS, Gorizontova MP, Mironova IV, Zinkevich VA. Effect of clofelin and propranolol on the development of neurogenic pain syndrome in rats. Patol Fiziol Eksp Ter 1993; 4: 16-9
34. Gorizontova MP, Mironova IV. [The effect of prophylactic administration of pentoxifylline (trental) on development of a neuropathic pain syndrome and microcirculatory disorders caused by it]. Biull Eksp Biol Med 1995;119: 485-7
35. Liu J, Feng X, Yu M, Xie W, Zhao X, Li W, Guan R, Xu J. Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain. Neurosci Lett 2007;412: 268-72
36. Ruddock MW, Hirst DG. Pentoxifylline inhibits agonist- induced vasoconstriction in vascular smooth muscle and spontaneous peristalsis in isolated ileum. Oncol Res 2005;15: 81-6
37. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP. Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock 1999;11: 269-75
38. Magnusson M, Gunnarsson M, Berntorp E, Björkman S, Höglund P. Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans. Eur J Pharmacol 2008;581: 290-5
39. Bhat VB, Madyastha KM. Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline. Biochem Biophys Res Commun 2001;288: 1212-7
40. Rice GC, Rosen J, Weeks R, Michnick J, Bursten S, Bianco JA, Singer JW. CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1994;1: 254-66
41. Waxman K, Daughters K, Aswani S, Rice G. Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock. Crit Care Med 1996;24: 1724-8
42. Du C, Cooper JC, Klaus SJ, Sriram S. Amelioration of CR-EAE with lisofylline: effects on mRNA levels of IL-12 and IFN- gamma in the CNS. J Neuroimmunol 2000;110: 13-9
43. Chen M, Yang Z, Wu R, Nadler JL. Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 2002;143: 2341-8
44. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53: 55-63
45. Millecamps M, Coderre TJ. Rats with chronic post-ischemia pain exhibit an analgesic sensitivity profile similar to human patients with complex regional pain syndrome-type I. Eur J Pharmacol 2008;583: 97-102
46. Kumar N, Laferriere A, Yu JS, Leavitt A, Coderre TJ. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 2010;113: 552-61
47. Stewart WC. Effect and side effects of apraclonidine. Klin Monbl Augenheilkd 1996;209:A7-13
48. Van Zwieten PA, Thoolen MJ, Timmermans PB. The pharmacology of centrally acting antihypertensive drugs. Br J Clin Pharmacol 1983;15(Suppl 4): 455S-62S
49. Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation 2012;19: 47-64
50. Creager MA. Clinical assessment of the patient with claudication: the role of the vascular laboratory. Vasc Med 1997;2: 231-7
51. Li C, Sekiyama H, Hayashida M, Takeda K, Sumida T, Sawamura S, Yamada Y, Arita H, Hanaoka K. Effects of topical application of clonidine cream on pain behaviors and spinal Fos protein expression in rat models of neuropathic pain, postoperative pain, and inflammatory pain. Anesthesiology 2007;107: 486-94
52. Groeneweg JG, Huygen FJ, Niehof SP, Wesseldijk F, Bussmann JB, Schasfoort FC, Stronks DL, Zijlstra FJ. No recovery of cold complex regional pain syndrome after transdermal isosorbide dinitrate: a small controlled trial. J Pain Symptom Manage 2009;38: 401-8
53. Groeneweg G, Huygen FJ, Niehof SP, Wesseldijk F, Bussmann JB, Schasfoort FC, Stronks DL, Zijlstra FJ. Effect of tadalafil on blood flow, pain, and function in chronic cold complex regional pain syndrome: a randomized controlled trial. BMC Musculoskelet Disord 2008;9: 143
54. Laferrière A, Pitcher MH, Haldane A, Huang Y, Cornea V, Kumar N, Sacktor TC, Cervero F, Coderre TJ. PKMζ is essential for spinal plasticity underlying the maintenance of persistent pain. Mol Pain 2011;7: 99
55. Munk SA, Harcourt D, Arasasingham P, Gluchowski C, Wong H, Burke J, Kharlamb A, Manlapaz C, Padillo E, Williams L, Wheeler L, Garst M. Analogs of UK 14304: structural features responsible for α2 adrenoceptor activity. Bioorg Med Chem Lett 1995;5: 1745-50
56. Alabaster V, Davey M. Precapillary vessels: effects of the sympathetic nervous system and of catecholamines. J Cardiovasc Pharmacol 1984;6 Suppl 2:S365-76
57. Ruffolo RR Jr. Distribution and function of peripheral alpha- adrenoceptors in the cardiovascular system. Pharmacol Biochem Behav 1985;22: 827-33
58. Wikberg-Matsson A, Simonsen U. Potent alpha (2A)-adrenoceptormediated vasoconstriction by brimonidine in porcine ciliary arteries. Invest Ophthalmol Vis Sci 2001;42: 2049-55
59. Costa VP, Harris A, Stefánsson E, Flammer J, Krieglstein GK, Orzalesi N, Heijl A, Renard JP, Serra LM. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 2003;22: 769-805